186 related articles for article (PubMed ID: 28440397)
1. Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.
Liu C; Lv D; Li M; Zhang X; Sun G; Bai Y; Chang D
Int J Oncol; 2017 Jun; 50(6):2079-2090. PubMed ID: 28440397
[TBL] [Abstract][Full Text] [Related]
2. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
4. A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against nonsmall-cell lung cancer.
Shieh JM; Tang YA; Hu FH; Huang WJ; Wang YJ; Jen J; Liao SY; Lu YH; Yeh YL; Wang TW; Lin P; Wang YC
Int J Cancer; 2017 May; 140(10):2375-2386. PubMed ID: 28233309
[TBL] [Abstract][Full Text] [Related]
5. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
[TBL] [Abstract][Full Text] [Related]
6. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
[TBL] [Abstract][Full Text] [Related]
7. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis.
Shukla S; Khan S; Kumar S; Sinha S; Farhan M; Bora HK; Maurya R; Meeran SM
Cancer Prev Res (Phila); 2015 Jun; 8(6):552-62. PubMed ID: 25813524
[TBL] [Abstract][Full Text] [Related]
9. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.
Hwang JA; Kim Y; Hong SH; Lee J; Cho YG; Han JY; Kim YH; Han J; Shim YM; Lee YS; Kim DH
PLoS One; 2013; 8(11):e79634. PubMed ID: 24265783
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer.
Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z
Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer.
Wang W; Zhao M; Cui L; Ren Y; Zhang J; Chen J; Jia L; Zhang J; Yang J; Chen G; Ashby CR; Wu C; Chen ZS; Wang L
Mol Cancer; 2020 Sep; 19(1):134. PubMed ID: 32878625
[TBL] [Abstract][Full Text] [Related]
15. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
16. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
19. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
